PanCareSurFup logo

Currently 80% of children and adolescents are expected to survive: however, many of these survivors may face significant long-term risks to their health and well-being. Since the cancer treatment is received during periods of growth and development, late effects are usually more severe than those experienced by adult cancer survivors.

PanCareSurFup – PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies is a consortium of 16 European institutions, funded by the FP7 (7th Framework Programme of the European Commission). PanCareSurFup partners carry out research studies into late effects of treatment for cancer, develop evidence-based guidelines for long-term care of childhood cancer survivors, disseminate the results and provide training and workshops for stakeholders.

PanCareSurFup’s studies are intended to lead to increased cooperation between treatment and advocacy groups, reduce disparities in survival and improve outcomes for children and adolescents diagnosed with cancer in Europe.FP7

SIOPE is an associate partner in the project, working on dissemination of the project activities.  The project commenced in February 2011, and will run until December 2016.

More information


c/o BLSI
Clos Chapelle-aux-Champs 30,
Bte 1.30.30
1200 Brussels

Tel: +32 2 880 62 82